251 - What’s New in Detection and Prevention of NTM Outbreaks

Saturday, October 19, 2024

1:45 PM – 3:00 PM US PT

Location: 515 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Nimalie Stone, MD, MS (she/her/hers)

Director, Medication Safety Program
Prevention and Response Branch
DHQP/CDC
Paris, KY, United States

Faculty(s)

Meghan Baker, MD, ScD (she/her/hers)

Associate Professor
Department of Population Medicine, Harvard Medical School Harvard Pilgrim Healthcare Institute
Boston, MA, United States
Kiran Perkins, MD, MPH

Lead, Outbreak Response Team, Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Atlanta, GA, United States
Kevin L Winthrop, MD, MPH (he/him/his)

Professor of Public Health, Infectious Diseases, Ophthalmology
Oregon Health & Science University
Portland, OR, United States

Disclosure(s):

Nimalie D. Stone, MD, MS: No financial relationships to disclose

Kathleen O'Donnell: No financial relationships to disclose

Meghan A. Baker, MD, ScD: No financial relationships to disclose

Kiran M. Perkins, MD, MPH: No financial relationships to disclose

Kevin L Winthrop, MD, MPH: AN2 Therapeutics, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Insmed Inc: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); MannKind: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Paratek Pharmaceuticals: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Renovion: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Spero theraputics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the current epidemiology and detection techniques for characterizing NTM outbreaks in US healthcare facilities;
identify strategies a hospital could implement to prevent NTM outbreaks;
determine an approach for monitoring clinical outcomes for patients impacted by an NTM outbreak.

Presentations:

1:45 PM – 2:10 PM US PT

Characterizing NTM Outbreaks Using Epidemiology and Genomics
Speaker: Kiran M. Perkins, MD, MPH – Centers for Disease Control and Prevention
2:10 PM – 2:35 PM US PT

Managing and Preventing NTM Outbreaks: Hospital Strategies
Speaker: Meghan A. Baker, MD, ScD (she/her/hers) – Department of Population Medicine, Harvard Medical School Harvard Pilgrim Healthcare Institute
2:35 PM – 3:00 PM US PT

Post-Outbreak Management: Monitoring Clinical Response and Patient Outcomes
Speaker: Kevin L Winthrop, MD, MPH (he/him/his) – Oregon Health & Science University